Ayodele Ayoola

Ayodele Ayoola serves as an Assistant Professor in the Department of Medicine, specifically within the Division of Hematology and Oncology. His academic and clinical work centers on advancing cancer treatment through research on targeted therapies and resistance mechanisms, with primary focus on lung, cervical, and hematologic malignancies.

His educational background includes:

• Doctor of Medicine (MD)
• Master of Public Health (MPH)
• Master of Science (MSc)

Dr. Ayoola's research spans multiple oncology domains including lung cancer (small-cell and non-small cell variants), targeted therapy resistance mechanisms, and community-based oncology practice. His work extends to gynecologic oncology metastasis patterns, breast cancer surgical decision-making via MRI, and lymphoma maintenance therapy. He investigates molecularly targeted agents and resistance challenges across diverse clinical settings to optimize patient outcomes.

Analysis of his 2010-2021 publications reveals consistent focus on treatment optimization through resistance mechanism studies and novel therapeutic evaluations. His work bridges lung cancer (EGFR inhibitors, small-cell variants), gynecologic oncology (cervical metastasis), breast cancer (MRI-guided surgery), and lymphoma (rituximab maintenance), demonstrating translational research that connects laboratory insights with community and academic clinical applications.